1231. Deputy Catherine Connolly asked the Minister for Health when patients in need of Spinraza will be able to access the drug; the length of time it will take and the criteria and conditions under which it will be available to patients; the reason there is no reference to its approval on the websites of the National Centre for Pharmacoeconomics, NCPE, and the HSE; and if he will make a statement on the matter. [32211/19]

Summary

1231. Deputy Catherine Connolly asked the Minister for Health when patients in need of Spinraza will be able to access the drug; the length of time it will take and the criteria and conditions under which it will be available to patients; the reason there is no reference to its approval on the websites of the National Centre for Pharmacoeconomics, NCPE, and the HSE; and if he will make a statement on the matter. [32211/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Availability

  xml · EN · 23 July 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.